nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine—CYP2B6—malignant glioma	0.587	1	CbGaD
Quinidine—CYP1A2—Carmustine—malignant glioma	0.0604	0.57	CbGbCtD
Quinidine—CYP3A4—Temozolomide—malignant glioma	0.0456	0.431	CbGbCtD
Quinidine—SLC22A8—choroid plexus—malignant glioma	0.013	0.151	CbGeAlD
Quinidine—ORM1—vertebral column—malignant glioma	0.00544	0.0632	CbGeAlD
Quinidine—Disorder sight—Temozolomide—malignant glioma	0.00321	0.0316	CcSEcCtD
Quinidine—Azotaemia—Carmustine—malignant glioma	0.00297	0.0292	CcSEcCtD
Quinidine—KCNK6—central nervous system—malignant glioma	0.00255	0.0296	CbGeAlD
Quinidine—Myasthenia—Carmustine—malignant glioma	0.00252	0.0248	CcSEcCtD
Quinidine—Aphasia—Carmustine—malignant glioma	0.00244	0.024	CcSEcCtD
Quinidine—Aphasia—Temozolomide—malignant glioma	0.00236	0.0232	CcSEcCtD
Quinidine—KCNK1—brainstem—malignant glioma	0.00224	0.026	CbGeAlD
Quinidine—Scotoma—Carmustine—malignant glioma	0.00209	0.0205	CcSEcCtD
Quinidine—Hepatotoxicity—Carmustine—malignant glioma	0.00205	0.0202	CcSEcCtD
Quinidine—KCNK6—brain—malignant glioma	0.00202	0.0235	CbGeAlD
Quinidine—Necrosis—Carmustine—malignant glioma	0.00202	0.0198	CcSEcCtD
Quinidine—Scotoma—Temozolomide—malignant glioma	0.00202	0.0198	CcSEcCtD
Quinidine—KCNK1—telencephalon—malignant glioma	0.00199	0.0231	CbGeAlD
Quinidine—Hepatotoxicity—Temozolomide—malignant glioma	0.00198	0.0195	CcSEcCtD
Quinidine—Coagulopathy—Temozolomide—malignant glioma	0.00197	0.0193	CcSEcCtD
Quinidine—Petechiae—Temozolomide—malignant glioma	0.00186	0.0183	CcSEcCtD
Quinidine—SCN1A—brainstem—malignant glioma	0.00166	0.0193	CbGeAlD
Quinidine—Hearing impaired—Temozolomide—malignant glioma	0.00161	0.0158	CcSEcCtD
Quinidine—KCNK1—medulla oblongata—malignant glioma	0.00156	0.0181	CbGeAlD
Quinidine—SCN2A—brainstem—malignant glioma	0.00152	0.0177	CbGeAlD
Quinidine—SCN1A—telencephalon—malignant glioma	0.00147	0.0171	CbGeAlD
Quinidine—Coma—Carmustine—malignant glioma	0.00145	0.0142	CcSEcCtD
Quinidine—Aplastic anaemia—Temozolomide—malignant glioma	0.00144	0.0141	CcSEcCtD
Quinidine—KCNK1—midbrain—malignant glioma	0.00143	0.0166	CbGeAlD
Quinidine—KCNK1—spinal cord—malignant glioma	0.00139	0.0162	CbGeAlD
Quinidine—SCN2A—telencephalon—malignant glioma	0.00135	0.0157	CbGeAlD
Quinidine—Deafness—Temozolomide—malignant glioma	0.00124	0.0122	CcSEcCtD
Quinidine—SCN3A—telencephalon—malignant glioma	0.00119	0.0138	CbGeAlD
Quinidine—Dermatitis exfoliative—Temozolomide—malignant glioma	0.00118	0.0116	CcSEcCtD
Quinidine—SCN1A—medulla oblongata—malignant glioma	0.00116	0.0135	CbGeAlD
Quinidine—Purpura—Temozolomide—malignant glioma	0.00115	0.0113	CcSEcCtD
Quinidine—Diplopia—Carmustine—malignant glioma	0.00115	0.0113	CcSEcCtD
Quinidine—KCNK1—central nervous system—malignant glioma	0.00113	0.0131	CbGeAlD
Quinidine—Diplopia—Temozolomide—malignant glioma	0.00111	0.0109	CcSEcCtD
Quinidine—KCNK1—cerebellum—malignant glioma	0.0011	0.0128	CbGeAlD
Quinidine—Ataxia—Carmustine—malignant glioma	0.00108	0.0106	CcSEcCtD
Quinidine—SCN2A—medulla oblongata—malignant glioma	0.00106	0.0124	CbGeAlD
Quinidine—Liver function test abnormal—Carmustine—malignant glioma	0.00106	0.0104	CcSEcCtD
Quinidine—SCN1A—midbrain—malignant glioma	0.00106	0.0123	CbGeAlD
Quinidine—Ataxia—Temozolomide—malignant glioma	0.00104	0.0103	CcSEcCtD
Quinidine—SCN1A—spinal cord—malignant glioma	0.00103	0.012	CbGeAlD
Quinidine—Muscular weakness—Carmustine—malignant glioma	0.00101	0.00997	CcSEcCtD
Quinidine—CHRM2—telencephalon—malignant glioma	0.00101	0.0117	CbGeAlD
Quinidine—Breast disorder—Temozolomide—malignant glioma	0.001	0.00987	CcSEcCtD
Quinidine—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.001	0.00984	CcSEcCtD
Quinidine—SLC22A1—telencephalon—malignant glioma	0.000992	0.0115	CbGeAlD
Quinidine—Muscular weakness—Temozolomide—malignant glioma	0.00098	0.00963	CcSEcCtD
Quinidine—SCN2A—midbrain—malignant glioma	0.000972	0.0113	CbGeAlD
Quinidine—SLCO1A2—telencephalon—malignant glioma	0.000955	0.0111	CbGeAlD
Quinidine—SCN2A—spinal cord—malignant glioma	0.000948	0.011	CbGeAlD
Quinidine—Pancytopenia—Carmustine—malignant glioma	0.000944	0.00928	CcSEcCtD
Quinidine—SCN3A—medulla oblongata—malignant glioma	0.000934	0.0109	CbGeAlD
Quinidine—Neutropenia—Carmustine—malignant glioma	0.000929	0.00913	CcSEcCtD
Quinidine—Pancytopenia—Temozolomide—malignant glioma	0.000912	0.00897	CcSEcCtD
Quinidine—Neutropenia—Temozolomide—malignant glioma	0.000898	0.00883	CcSEcCtD
Quinidine—KCNK1—brain—malignant glioma	0.000896	0.0104	CbGeAlD
Quinidine—Photosensitivity reaction—Temozolomide—malignant glioma	0.000876	0.00862	CcSEcCtD
Quinidine—Renal failure—Carmustine—malignant glioma	0.000871	0.00856	CcSEcCtD
Quinidine—SCN3A—midbrain—malignant glioma	0.000854	0.00992	CbGeAlD
Quinidine—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.000849	0.00835	CcSEcCtD
Quinidine—SCN1A—central nervous system—malignant glioma	0.000838	0.00974	CbGeAlD
Quinidine—SCN3A—spinal cord—malignant glioma	0.000833	0.00968	CbGeAlD
Quinidine—SCN1A—cerebellum—malignant glioma	0.000819	0.00952	CbGeAlD
Quinidine—Haemoglobin—Carmustine—malignant glioma	0.000799	0.00786	CcSEcCtD
Quinidine—Haemorrhage—Carmustine—malignant glioma	0.000795	0.00782	CcSEcCtD
Quinidine—Haemoglobin—Temozolomide—malignant glioma	0.000772	0.00759	CcSEcCtD
Quinidine—SCN2A—central nervous system—malignant glioma	0.000769	0.00894	CbGeAlD
Quinidine—Hepatitis—Temozolomide—malignant glioma	0.000769	0.00756	CcSEcCtD
Quinidine—Haemorrhage—Temozolomide—malignant glioma	0.000769	0.00756	CcSEcCtD
Quinidine—Visual impairment—Carmustine—malignant glioma	0.000766	0.00754	CcSEcCtD
Quinidine—Urinary tract disorder—Temozolomide—malignant glioma	0.000759	0.00746	CcSEcCtD
Quinidine—ORM1—spinal cord—malignant glioma	0.000758	0.00881	CbGeAlD
Quinidine—Urethral disorder—Temozolomide—malignant glioma	0.000753	0.00741	CcSEcCtD
Quinidine—SCN2A—cerebellum—malignant glioma	0.000752	0.00873	CbGeAlD
Quinidine—SLCO1A2—medulla oblongata—malignant glioma	0.00075	0.00872	CbGeAlD
Quinidine—SLC22A5—retina—malignant glioma	0.000749	0.0087	CbGeAlD
Quinidine—Eye disorder—Carmustine—malignant glioma	0.000743	0.00731	CcSEcCtD
Quinidine—Visual impairment—Temozolomide—malignant glioma	0.000741	0.00728	CcSEcCtD
Quinidine—Flushing—Carmustine—malignant glioma	0.000738	0.00726	CcSEcCtD
Quinidine—SLC22A4—spinal cord—malignant glioma	0.00073	0.00848	CbGeAlD
Quinidine—KCNH2—telencephalon—malignant glioma	0.000729	0.00847	CbGeAlD
Quinidine—Erythema multiforme—Temozolomide—malignant glioma	0.000727	0.00714	CcSEcCtD
Quinidine—Eye disorder—Temozolomide—malignant glioma	0.000718	0.00706	CcSEcCtD
Quinidine—Tinnitus—Temozolomide—malignant glioma	0.000717	0.00705	CcSEcCtD
Quinidine—Cardiac disorder—Temozolomide—malignant glioma	0.000713	0.00701	CcSEcCtD
Quinidine—Flushing—Temozolomide—malignant glioma	0.000713	0.00701	CcSEcCtD
Quinidine—Mental disorder—Carmustine—malignant glioma	0.000697	0.00685	CcSEcCtD
Quinidine—Immune system disorder—Temozolomide—malignant glioma	0.000694	0.00683	CcSEcCtD
Quinidine—Mediastinal disorder—Temozolomide—malignant glioma	0.000693	0.00681	CcSEcCtD
Quinidine—Malnutrition—Carmustine—malignant glioma	0.000692	0.00681	CcSEcCtD
Quinidine—Erythema—Carmustine—malignant glioma	0.000692	0.00681	CcSEcCtD
Quinidine—Chills—Temozolomide—malignant glioma	0.00069	0.00678	CcSEcCtD
Quinidine—SLCO1A2—midbrain—malignant glioma	0.000686	0.00797	CbGeAlD
Quinidine—SCN3A—central nervous system—malignant glioma	0.000676	0.00785	CbGeAlD
Quinidine—SCN5A—central nervous system—malignant glioma	0.000674	0.00783	CbGeAlD
Quinidine—Mental disorder—Temozolomide—malignant glioma	0.000673	0.00662	CcSEcCtD
Quinidine—Erythema—Temozolomide—malignant glioma	0.000669	0.00658	CcSEcCtD
Quinidine—Malnutrition—Temozolomide—malignant glioma	0.000669	0.00658	CcSEcCtD
Quinidine—SLCO1A2—spinal cord—malignant glioma	0.000669	0.00777	CbGeAlD
Quinidine—SCN1A—brain—malignant glioma	0.000665	0.00773	CbGeAlD
Quinidine—SCN3A—cerebellum—malignant glioma	0.000661	0.00768	CbGeAlD
Quinidine—ABCB1—blood vessel—malignant glioma	0.000659	0.00766	CbGeAlD
Quinidine—Vision blurred—Carmustine—malignant glioma	0.000652	0.00641	CcSEcCtD
Quinidine—Tremor—Carmustine—malignant glioma	0.000649	0.00638	CcSEcCtD
Quinidine—Agitation—Carmustine—malignant glioma	0.000636	0.00626	CcSEcCtD
Quinidine—Vision blurred—Temozolomide—malignant glioma	0.000631	0.0062	CcSEcCtD
Quinidine—Tremor—Temozolomide—malignant glioma	0.000627	0.00616	CcSEcCtD
Quinidine—Leukopenia—Carmustine—malignant glioma	0.00062	0.00609	CcSEcCtD
Quinidine—ORM1—central nervous system—malignant glioma	0.000615	0.00715	CbGeAlD
Quinidine—Agitation—Temozolomide—malignant glioma	0.000615	0.00604	CcSEcCtD
Quinidine—Angioedema—Temozolomide—malignant glioma	0.000611	0.00601	CcSEcCtD
Quinidine—SCN2A—brain—malignant glioma	0.000611	0.00709	CbGeAlD
Quinidine—Vertigo—Temozolomide—malignant glioma	0.000601	0.00591	CcSEcCtD
Quinidine—Convulsion—Carmustine—malignant glioma	0.0006	0.0059	CcSEcCtD
Quinidine—Leukopenia—Temozolomide—malignant glioma	0.000599	0.00589	CcSEcCtD
Quinidine—Palpitations—Temozolomide—malignant glioma	0.000591	0.00581	CcSEcCtD
Quinidine—Myalgia—Carmustine—malignant glioma	0.000589	0.00579	CcSEcCtD
Quinidine—Chest pain—Carmustine—malignant glioma	0.000589	0.00579	CcSEcCtD
Quinidine—Convulsion—Temozolomide—malignant glioma	0.00058	0.0057	CcSEcCtD
Quinidine—SLC22A4—cerebellum—malignant glioma	0.000579	0.00672	CbGeAlD
Quinidine—CHRM2—central nervous system—malignant glioma	0.000574	0.00667	CbGeAlD
Quinidine—KCNH2—medulla oblongata—malignant glioma	0.000573	0.00666	CbGeAlD
Quinidine—Confusional state—Carmustine—malignant glioma	0.00057	0.0056	CcSEcCtD
Quinidine—Myalgia—Temozolomide—malignant glioma	0.00057	0.0056	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000566	0.00556	CcSEcCtD
Quinidine—Oedema—Carmustine—malignant glioma	0.000565	0.00556	CcSEcCtD
Quinidine—SLC22A1—central nervous system—malignant glioma	0.000564	0.00655	CbGeAlD
Quinidine—CYP2E1—telencephalon—malignant glioma	0.000562	0.00652	CbGeAlD
Quinidine—Thrombocytopenia—Carmustine—malignant glioma	0.000553	0.00544	CcSEcCtD
Quinidine—Tachycardia—Carmustine—malignant glioma	0.000551	0.00542	CcSEcCtD
Quinidine—Confusional state—Temozolomide—malignant glioma	0.000551	0.00541	CcSEcCtD
Quinidine—Oedema—Temozolomide—malignant glioma	0.000546	0.00537	CcSEcCtD
Quinidine—SLCO1A2—central nervous system—malignant glioma	0.000543	0.0063	CbGeAlD
Quinidine—SLC22A5—medulla oblongata—malignant glioma	0.000541	0.00629	CbGeAlD
Quinidine—Anorexia—Carmustine—malignant glioma	0.000539	0.0053	CcSEcCtD
Quinidine—SCN3A—brain—malignant glioma	0.000537	0.00623	CbGeAlD
Quinidine—Nervous system disorder—Temozolomide—malignant glioma	0.000535	0.00526	CcSEcCtD
Quinidine—SCN5A—brain—malignant glioma	0.000535	0.00622	CbGeAlD
Quinidine—Thrombocytopenia—Temozolomide—malignant glioma	0.000535	0.00526	CcSEcCtD
Quinidine—SLCO1A2—cerebellum—malignant glioma	0.00053	0.00616	CbGeAlD
Quinidine—Skin disorder—Temozolomide—malignant glioma	0.00053	0.00521	CcSEcCtD
Quinidine—Hypotension—Carmustine—malignant glioma	0.000528	0.00519	CcSEcCtD
Quinidine—Hyperhidrosis—Temozolomide—malignant glioma	0.000528	0.00519	CcSEcCtD
Quinidine—KCNH2—midbrain—malignant glioma	0.000524	0.00608	CbGeAlD
Quinidine—Anorexia—Temozolomide—malignant glioma	0.00052	0.00512	CcSEcCtD
Quinidine—SLC22A8—central nervous system—malignant glioma	0.000518	0.00602	CbGeAlD
Quinidine—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000515	0.00506	CcSEcCtD
Quinidine—KCNH2—spinal cord—malignant glioma	0.000511	0.00593	CbGeAlD
Quinidine—Dyspnoea—Carmustine—malignant glioma	0.000504	0.00495	CcSEcCtD
Quinidine—CYP2D6—brainstem—malignant glioma	0.000501	0.00582	CbGeAlD
Quinidine—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000497	0.00489	CcSEcCtD
Quinidine—SLC22A5—midbrain—malignant glioma	0.000495	0.00575	CbGeAlD
Quinidine—Decreased appetite—Carmustine—malignant glioma	0.000491	0.00483	CcSEcCtD
Quinidine—Gastrointestinal disorder—Carmustine—malignant glioma	0.000488	0.0048	CcSEcCtD
Quinidine—Dyspnoea—Temozolomide—malignant glioma	0.000487	0.00479	CcSEcCtD
Quinidine—SLC22A5—spinal cord—malignant glioma	0.000483	0.00561	CbGeAlD
Quinidine—Decreased appetite—Temozolomide—malignant glioma	0.000475	0.00467	CcSEcCtD
Quinidine—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000471	0.00463	CcSEcCtD
Quinidine—SLC22A4—brain—malignant glioma	0.00047	0.00546	CbGeAlD
Quinidine—Feeling abnormal—Carmustine—malignant glioma	0.000466	0.00458	CcSEcCtD
Quinidine—Gastrointestinal pain—Carmustine—malignant glioma	0.000462	0.00454	CcSEcCtD
Quinidine—CHRM2—brain—malignant glioma	0.000456	0.00529	CbGeAlD
Quinidine—Feeling abnormal—Temozolomide—malignant glioma	0.00045	0.00442	CcSEcCtD
Quinidine—SLC22A1—brain—malignant glioma	0.000447	0.0052	CbGeAlD
Quinidine—Abdominal pain—Carmustine—malignant glioma	0.000447	0.00439	CcSEcCtD
Quinidine—Body temperature increased—Carmustine—malignant glioma	0.000447	0.00439	CcSEcCtD
Quinidine—Gastrointestinal pain—Temozolomide—malignant glioma	0.000447	0.00439	CcSEcCtD
Quinidine—CYP2D6—telencephalon—malignant glioma	0.000445	0.00517	CbGeAlD
Quinidine—CYP2E1—medulla oblongata—malignant glioma	0.000441	0.00513	CbGeAlD
Quinidine—Urticaria—Temozolomide—malignant glioma	0.000434	0.00426	CcSEcCtD
Quinidine—Body temperature increased—Temozolomide—malignant glioma	0.000432	0.00424	CcSEcCtD
Quinidine—Abdominal pain—Temozolomide—malignant glioma	0.000432	0.00424	CcSEcCtD
Quinidine—SLCO1A2—brain—malignant glioma	0.000431	0.00501	CbGeAlD
Quinidine—Hypersensitivity—Carmustine—malignant glioma	0.000416	0.00409	CcSEcCtD
Quinidine—KCNH2—central nervous system—malignant glioma	0.000414	0.00481	CbGeAlD
Quinidine—SLC22A8—brain—malignant glioma	0.000411	0.00478	CbGeAlD
Quinidine—Asthenia—Carmustine—malignant glioma	0.000405	0.00399	CcSEcCtD
Quinidine—KCNH2—cerebellum—malignant glioma	0.000405	0.00471	CbGeAlD
Quinidine—Hypersensitivity—Temozolomide—malignant glioma	0.000402	0.00396	CcSEcCtD
Quinidine—CYP2E1—spinal cord—malignant glioma	0.000393	0.00457	CbGeAlD
Quinidine—ABCB1—embryo—malignant glioma	0.000393	0.00457	CbGeAlD
Quinidine—Asthenia—Temozolomide—malignant glioma	0.000392	0.00385	CcSEcCtD
Quinidine—Diarrhoea—Carmustine—malignant glioma	0.000387	0.0038	CcSEcCtD
Quinidine—Pruritus—Temozolomide—malignant glioma	0.000386	0.0038	CcSEcCtD
Quinidine—SLC22A5—cerebellum—malignant glioma	0.000383	0.00445	CbGeAlD
Quinidine—Dizziness—Carmustine—malignant glioma	0.000374	0.00367	CcSEcCtD
Quinidine—Diarrhoea—Temozolomide—malignant glioma	0.000374	0.00367	CcSEcCtD
Quinidine—Dizziness—Temozolomide—malignant glioma	0.000361	0.00355	CcSEcCtD
Quinidine—Vomiting—Carmustine—malignant glioma	0.000359	0.00353	CcSEcCtD
Quinidine—Rash—Carmustine—malignant glioma	0.000356	0.0035	CcSEcCtD
Quinidine—Dermatitis—Carmustine—malignant glioma	0.000356	0.0035	CcSEcCtD
Quinidine—Headache—Carmustine—malignant glioma	0.000354	0.00348	CcSEcCtD
Quinidine—CYP1A1—central nervous system—malignant glioma	0.00035	0.00407	CbGeAlD
Quinidine—ABCB1—retina—malignant glioma	0.000348	0.00404	CbGeAlD
Quinidine—Vomiting—Temozolomide—malignant glioma	0.000347	0.00341	CcSEcCtD
Quinidine—Rash—Temozolomide—malignant glioma	0.000344	0.00338	CcSEcCtD
Quinidine—Dermatitis—Temozolomide—malignant glioma	0.000344	0.00338	CcSEcCtD
Quinidine—Headache—Temozolomide—malignant glioma	0.000342	0.00336	CcSEcCtD
Quinidine—CYP2B6—central nervous system—malignant glioma	0.00034	0.00395	CbGeAlD
Quinidine—Nausea—Carmustine—malignant glioma	0.000336	0.0033	CcSEcCtD
Quinidine—KCNH2—brain—malignant glioma	0.000329	0.00382	CbGeAlD
Quinidine—Nausea—Temozolomide—malignant glioma	0.000324	0.00319	CcSEcCtD
Quinidine—ABCB1—telencephalon—malignant glioma	0.00032	0.00372	CbGeAlD
Quinidine—CYP2E1—central nervous system—malignant glioma	0.000319	0.00371	CbGeAlD
Quinidine—CYP2E1—cerebellum—malignant glioma	0.000312	0.00362	CbGeAlD
Quinidine—SLC22A5—brain—malignant glioma	0.000311	0.00361	CbGeAlD
Quinidine—CYP2C8—brain—malignant glioma	0.000301	0.0035	CbGeAlD
Quinidine—CYP1A1—brain—malignant glioma	0.000278	0.00323	CbGeAlD
Quinidine—CYP2B6—brain—malignant glioma	0.00027	0.00314	CbGeAlD
Quinidine—CYP3A4—central nervous system—malignant glioma	0.000257	0.00298	CbGeAlD
Quinidine—CYP2E1—brain—malignant glioma	0.000253	0.00294	CbGeAlD
Quinidine—CYP2D6—central nervous system—malignant glioma	0.000253	0.00294	CbGeAlD
Quinidine—ABCB1—medulla oblongata—malignant glioma	0.000251	0.00292	CbGeAlD
Quinidine—CYP2D6—cerebellum—malignant glioma	0.000247	0.00287	CbGeAlD
Quinidine—ABCB1—midbrain—malignant glioma	0.00023	0.00267	CbGeAlD
Quinidine—ABCB1—spinal cord—malignant glioma	0.000224	0.0026	CbGeAlD
Quinidine—CYP2D6—brain—malignant glioma	0.000201	0.00233	CbGeAlD
Quinidine—ABCB1—central nervous system—malignant glioma	0.000182	0.00211	CbGeAlD
Quinidine—ABCB1—cerebellum—malignant glioma	0.000178	0.00206	CbGeAlD
Quinidine—ABCB1—brain—malignant glioma	0.000144	0.00168	CbGeAlD
Quinidine—SLCO1B1—Metabolism—PIK3CG—malignant glioma	1.01e-05	8.49e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—GSTT1—malignant glioma	1.01e-05	8.47e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—GSTP1—malignant glioma	1.01e-05	8.45e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PTGS1—malignant glioma	1.01e-05	8.42e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—IDH2—malignant glioma	1e-05	8.4e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—GSTT1—malignant glioma	1e-05	8.4e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1e-05	8.4e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	9.99e-06	8.37e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	9.93e-06	8.32e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—GSTP1—malignant glioma	9.88e-06	8.27e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—PIK3CD—malignant glioma	9.85e-06	8.26e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—CAT—malignant glioma	9.81e-06	8.22e-05	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—PPARG—malignant glioma	9.78e-06	8.2e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—CAT—malignant glioma	9.61e-06	8.05e-05	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—CAV1—malignant glioma	9.5e-06	7.96e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—MMP3—malignant glioma	9.49e-06	7.95e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PTGS1—malignant glioma	9.47e-06	7.94e-05	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—PIK3CB—malignant glioma	9.46e-06	7.92e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	9.45e-06	7.91e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—CYP2B6—malignant glioma	9.43e-06	7.9e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CDKN2B—malignant glioma	9.4e-06	7.88e-05	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—PTEN—malignant glioma	9.4e-06	7.88e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PTGS1—malignant glioma	9.39e-06	7.87e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	9.36e-06	7.84e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—BCHE—malignant glioma	9.35e-06	7.83e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—GSTP1—malignant glioma	9.31e-06	7.8e-05	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—PIK3CG—malignant glioma	9.3e-06	7.79e-05	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—PIK3CG—malignant glioma	9.29e-06	7.78e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—NCOR1—malignant glioma	9.27e-06	7.76e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—SLC5A5—malignant glioma	9.23e-06	7.73e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PTK2—malignant glioma	9.13e-06	7.65e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	9.1e-06	7.62e-05	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—CXCL8—malignant glioma	9.09e-06	7.61e-05	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—PIK3CB—malignant glioma	9.08e-06	7.61e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—NCOR1—malignant glioma	9.07e-06	7.6e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—CAT—malignant glioma	9.06e-06	7.59e-05	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—PTGS2—malignant glioma	9e-06	7.54e-05	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—PPARG—malignant glioma	8.98e-06	7.52e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—HES1—malignant glioma	8.97e-06	7.51e-05	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—PPARG—malignant glioma	8.96e-06	7.51e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—NCOR1—malignant glioma	8.92e-06	7.47e-05	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—PIK3CD—malignant glioma	8.91e-06	7.46e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—BCHE—malignant glioma	8.81e-06	7.38e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—RAF1—malignant glioma	8.8e-06	7.37e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	8.78e-06	7.35e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—BCHE—malignant glioma	8.73e-06	7.31e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—SLC5A5—malignant glioma	8.7e-06	7.29e-05	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—IL2—malignant glioma	8.69e-06	7.28e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	8.66e-06	7.25e-05	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—PIK3CG—malignant glioma	8.66e-06	7.25e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—SLC5A5—malignant glioma	8.62e-06	7.22e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—IDH1—malignant glioma	8.62e-06	7.22e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—PIK3CB—malignant glioma	8.59e-06	7.2e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—GSTT1—malignant glioma	8.56e-06	7.17e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—NCOR1—malignant glioma	8.56e-06	7.17e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PDGFRA—malignant glioma	8.54e-06	7.15e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—GSTP1—malignant glioma	8.54e-06	7.15e-05	CbGpPWpGaD
Quinidine—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	8.5e-06	7.12e-05	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—PPARG—malignant glioma	8.36e-06	7e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—SPHK1—malignant glioma	8.34e-06	6.99e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—CAT—malignant glioma	8.31e-06	6.96e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—SPP1—malignant glioma	8.29e-06	6.95e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—CXCL8—malignant glioma	8.25e-06	6.91e-05	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—PIK3CD—malignant glioma	8.18e-06	6.85e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—CYP2C18—malignant glioma	8.17e-06	6.85e-05	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—PIK3CD—malignant glioma	8.17e-06	6.84e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	8.16e-06	6.83e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	8.08e-06	6.77e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PTGS1—malignant glioma	8.03e-06	6.72e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	8e-06	6.7e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—IL2—malignant glioma	7.89e-06	6.61e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—TERT—malignant glioma	7.86e-06	6.58e-05	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—PTEN—malignant glioma	7.85e-06	6.57e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—NCOR1—malignant glioma	7.84e-06	6.57e-05	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—PIK3CB—malignant glioma	7.77e-06	6.51e-05	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—PTGS2—malignant glioma	7.7e-06	6.45e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PDGFB—malignant glioma	7.67e-06	6.43e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—FGFR1—malignant glioma	7.63e-06	6.39e-05	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—PIK3CD—malignant glioma	7.61e-06	6.38e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—CAV1—malignant glioma	7.55e-06	6.33e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—HIF1A—malignant glioma	7.52e-06	6.3e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—BCHE—malignant glioma	7.46e-06	6.25e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—GSTP1—malignant glioma	7.44e-06	6.23e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—CAV1—malignant glioma	7.4e-06	6.2e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—SLC5A5—malignant glioma	7.37e-06	6.17e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CAV1—malignant glioma	7.27e-06	6.09e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—CAT—malignant glioma	7.24e-06	6.06e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—KDR—malignant glioma	7.19e-06	6.02e-05	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—PIK3CB—malignant glioma	7.13e-06	5.97e-05	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—PIK3CB—malignant glioma	7.12e-06	5.96e-05	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—PTGS2—malignant glioma	7.06e-06	5.92e-05	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—PTGS2—malignant glioma	7.05e-06	5.91e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	7.05e-06	5.9e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—GSTP1—malignant glioma	7.01e-06	5.87e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—CAV1—malignant glioma	6.97e-06	5.84e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	6.97e-06	5.84e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—GSTP1—malignant glioma	6.95e-06	5.82e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—F2—malignant glioma	6.92e-06	5.8e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—FN1—malignant glioma	6.92e-06	5.8e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	6.91e-06	5.79e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PIK3CG—malignant glioma	6.88e-06	5.76e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—BAD—malignant glioma	6.84e-06	5.73e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—NCOR1—malignant glioma	6.83e-06	5.72e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—CAT—malignant glioma	6.82e-06	5.71e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—NOTCH1—malignant glioma	6.77e-06	5.67e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—CAT—malignant glioma	6.76e-06	5.66e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PIK3CG—malignant glioma	6.74e-06	5.65e-05	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—PTEN—malignant glioma	6.71e-06	5.62e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	6.66e-06	5.58e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PPARG—malignant glioma	6.64e-06	5.56e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CD80—malignant glioma	6.63e-06	5.56e-05	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—PIK3CB—malignant glioma	6.63e-06	5.56e-05	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—PIK3CA—malignant glioma	6.63e-06	5.56e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PIK3CG—malignant glioma	6.62e-06	5.55e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—APC—malignant glioma	6.62e-06	5.55e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—GSTT1—malignant glioma	6.61e-06	5.54e-05	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—PTGS2—malignant glioma	6.57e-06	5.51e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—EGF—malignant glioma	6.55e-06	5.48e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PTPN11—malignant glioma	6.51e-06	5.45e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PPARG—malignant glioma	6.5e-06	5.45e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—NCOR1—malignant glioma	6.44e-06	5.39e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—CAV1—malignant glioma	6.39e-06	5.36e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—NCOR1—malignant glioma	6.38e-06	5.35e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PIK3CG—malignant glioma	6.35e-06	5.32e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—BRAF—malignant glioma	6.22e-06	5.21e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PTGS1—malignant glioma	6.19e-06	5.19e-05	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—PTEN—malignant glioma	6.16e-06	5.16e-05	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—PTEN—malignant glioma	6.15e-06	5.15e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PPARG—malignant glioma	6.13e-06	5.14e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	6.11e-06	5.12e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—AKT2—malignant glioma	6.06e-06	5.08e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PIK3CD—malignant glioma	6.05e-06	5.07e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—EGFR—malignant glioma	6.03e-06	5.05e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	6.02e-06	5.05e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—GSTP1—malignant glioma	5.94e-06	4.97e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PIK3CD—malignant glioma	5.92e-06	4.96e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PIK3CG—malignant glioma	5.82e-06	4.88e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PIK3CD—malignant glioma	5.82e-06	4.88e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—CAT—malignant glioma	5.78e-06	4.84e-05	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—PIK3CA—malignant glioma	5.77e-06	4.83e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—BCHE—malignant glioma	5.76e-06	4.82e-05	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—PTEN—malignant glioma	5.73e-06	4.8e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—KRAS—malignant glioma	5.7e-06	4.77e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—SLC5A5—malignant glioma	5.69e-06	4.76e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PPARG—malignant glioma	5.62e-06	4.71e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PIK3CD—malignant glioma	5.59e-06	4.68e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—FGF2—malignant glioma	5.57e-06	4.67e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—CAV1—malignant glioma	5.57e-06	4.67e-05	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—PIK3CA—malignant glioma	5.54e-06	4.64e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—NCOR1—malignant glioma	5.46e-06	4.57e-05	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—AKT1—malignant glioma	5.42e-06	4.54e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PIK3CB—malignant glioma	5.27e-06	4.42e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—CAV1—malignant glioma	5.25e-06	4.4e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—PIK3CA—malignant glioma	5.24e-06	4.39e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PTGS2—malignant glioma	5.22e-06	4.38e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—MDM2—malignant glioma	5.22e-06	4.37e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—CAV1—malignant glioma	5.2e-06	4.36e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—RAF1—malignant glioma	5.2e-06	4.35e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PIK3CB—malignant glioma	5.16e-06	4.33e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—ERBB2—malignant glioma	5.14e-06	4.31e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PIK3CD—malignant glioma	5.12e-06	4.29e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PTGS2—malignant glioma	5.12e-06	4.29e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PIK3CG—malignant glioma	5.07e-06	4.25e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PIK3CB—malignant glioma	5.07e-06	4.25e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.97e-06	4.17e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PPARG—malignant glioma	4.9e-06	4.1e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CXCL8—malignant glioma	4.88e-06	4.08e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PIK3CB—malignant glioma	4.87e-06	4.08e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PTGS2—malignant glioma	4.82e-06	4.04e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PIK3CG—malignant glioma	4.78e-06	4.01e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PIK3CG—malignant glioma	4.74e-06	3.97e-05	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—PIK3CA—malignant glioma	4.73e-06	3.97e-05	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—AKT1—malignant glioma	4.71e-06	3.95e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CASP3—malignant glioma	4.67e-06	3.91e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—IL2—malignant glioma	4.66e-06	3.9e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PPARG—malignant glioma	4.62e-06	3.87e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—GSTP1—malignant glioma	4.58e-06	3.84e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PPARG—malignant glioma	4.58e-06	3.83e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PTEN—malignant glioma	4.56e-06	3.82e-05	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—AKT1—malignant glioma	4.52e-06	3.79e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PIK3CB—malignant glioma	4.46e-06	3.74e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PTEN—malignant glioma	4.46e-06	3.74e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PIK3CD—malignant glioma	4.46e-06	3.74e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—CAT—malignant glioma	4.46e-06	3.73e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—CAV1—malignant glioma	4.45e-06	3.73e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PTGS2—malignant glioma	4.42e-06	3.7e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—MMP9—malignant glioma	4.41e-06	3.69e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PTEN—malignant glioma	4.38e-06	3.67e-05	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—PIK3CA—malignant glioma	4.35e-06	3.64e-05	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—PIK3CA—malignant glioma	4.34e-06	3.63e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—AKT1—malignant glioma	4.28e-06	3.58e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.25e-06	3.56e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—NCOR1—malignant glioma	4.21e-06	3.53e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PTEN—malignant glioma	4.21e-06	3.52e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PIK3CD—malignant glioma	4.2e-06	3.52e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PIK3CD—malignant glioma	4.17e-06	3.49e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PIK3CG—malignant glioma	4.05e-06	3.39e-05	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—PIK3CA—malignant glioma	4.04e-06	3.39e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—VEGFA—malignant glioma	3.96e-06	3.32e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—STAT3—malignant glioma	3.92e-06	3.29e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PPARG—malignant glioma	3.91e-06	3.28e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PIK3CB—malignant glioma	3.89e-06	3.26e-05	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—AKT1—malignant glioma	3.87e-06	3.24e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PTEN—malignant glioma	3.86e-06	3.23e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PTGS2—malignant glioma	3.85e-06	3.23e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PIK3CB—malignant glioma	3.66e-06	3.07e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—MYC—malignant glioma	3.64e-06	3.05e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PIK3CB—malignant glioma	3.63e-06	3.04e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PTGS2—malignant glioma	3.63e-06	3.04e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PTGS2—malignant glioma	3.6e-06	3.02e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—EGFR—malignant glioma	3.56e-06	2.99e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PIK3CD—malignant glioma	3.56e-06	2.98e-05	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—AKT1—malignant glioma	3.55e-06	2.97e-05	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—AKT1—malignant glioma	3.54e-06	2.97e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—CAV1—malignant glioma	3.43e-06	2.88e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—KRAS—malignant glioma	3.37e-06	2.82e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PTEN—malignant glioma	3.36e-06	2.81e-05	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—AKT1—malignant glioma	3.3e-06	2.77e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PIK3CA—malignant glioma	3.21e-06	2.69e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PTEN—malignant glioma	3.17e-06	2.65e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PIK3CA—malignant glioma	3.15e-06	2.64e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PTEN—malignant glioma	3.14e-06	2.63e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PIK3CG—malignant glioma	3.13e-06	2.62e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PIK3CB—malignant glioma	3.1e-06	2.6e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PIK3CA—malignant glioma	3.09e-06	2.59e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PTGS2—malignant glioma	3.08e-06	2.58e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PPARG—malignant glioma	3.02e-06	2.53e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—TP53—malignant glioma	2.99e-06	2.51e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PIK3CA—malignant glioma	2.97e-06	2.49e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PIK3CD—malignant glioma	2.75e-06	2.3e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PIK3CA—malignant glioma	2.72e-06	2.28e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PTEN—malignant glioma	2.68e-06	2.25e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—AKT1—malignant glioma	2.63e-06	2.2e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—AKT1—malignant glioma	2.57e-06	2.15e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—AKT1—malignant glioma	2.53e-06	2.12e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—AKT1—malignant glioma	2.42e-06	2.03e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PIK3CB—malignant glioma	2.4e-06	2.01e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PTGS2—malignant glioma	2.37e-06	1.99e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PIK3CA—malignant glioma	2.37e-06	1.99e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PIK3CA—malignant glioma	2.23e-06	1.87e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—AKT1—malignant glioma	2.22e-06	1.86e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PIK3CA—malignant glioma	2.21e-06	1.85e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PTEN—malignant glioma	2.07e-06	1.73e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—AKT1—malignant glioma	1.94e-06	1.62e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PIK3CA—malignant glioma	1.89e-06	1.59e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—AKT1—malignant glioma	1.82e-06	1.53e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—AKT1—malignant glioma	1.81e-06	1.52e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—AKT1—malignant glioma	1.55e-06	1.29e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.46e-06	1.22e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—AKT1—malignant glioma	1.19e-06	9.99e-06	CbGpPWpGaD
